Equity Capital Markets

Company · CIK 1819411

Gain Therapeutics, Inc.

CIK1819411 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressMD
ListedGANX (Nasdaq)
First annual or quarterly report2021-05-10

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-287622
ShelfEffective
 2025-05-282025-11-282
333-265061
ShelfEffective
 2022-05-182025-07-179
333-276145
Registered companyEffective
 2023-12-192023-12-292
333-253303
IPOFinal prospectus
 2021-02-192021-03-225

Filings

19
FiledFilingRegistrationAccession
2025-11-28424B5Shelf takedown 333-2876220001104659-25-116944
2025-07-17424B5Shelf takedown 333-2650610001104659-25-068532
2025-07-15424B5Shelf takedown 333-2650610001104659-25-068103
2025-05-28S-3Shelf registered 333-2876220001104659-25-053619
2024-09-06424B5Shelf takedown 333-2650610001104659-24-097782
2024-06-17424B5Shelf takedown 333-2650610001104659-24-072053
2024-06-13424B5Shelf takedown 333-2650610001104659-24-071307
2023-12-29EFFECTDeclared effective 333-2761459999999995-24-000017
2023-12-19S-1Registration filed 333-2761450001104659-23-127362
2023-11-24424B5Shelf takedown 333-2650610001104659-23-120867
2023-11-20424B5Shelf takedown 333-2650610001104659-23-119934
2022-06-01EFFECTDeclared effective 333-2650619999999995-22-001659
2022-05-18S-3Shelf registered 333-2650610001104659-22-062504
2021-03-22424B4Final prospectus 333-2533030001140361-21-009381
2021-03-17EFFECTDeclared effective 333-2533039999999995-21-000974
2021-03-15S-1/AAmendment 333-2533030001140361-21-008499
2021-03-10S-1/AAmendment 333-2533030001140361-21-007922
2021-02-19S-1Registration filed 333-2533030001140361-21-005495
2020-11-16DRSDraft made public 377-037890001140361-20-025683

All filings of this company · CSV